{
    "Trade/Device Name(s)": [
        "Diazyme Carbon Dioxide Enzymatic Assay",
        "Bicarbonate/Carbon Dioxide Test System",
        "Diazyme Carbon Dioxide Enzymatic Assay Kit",
        "Diazyme Carbon Dioxide Control Set"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "k060619",
    "Predicate Device Reference 510(k) Number(s)": [
        "k990754"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS",
        "JJX"
    ],
    "Summary Letter Date": "July 21, 2006",
    "Summary Letter Received Date": "July 7, 2006",
    "Submission Date": "June 30, 2006",
    "Regulation Number(s)": [
        "21 CFR\u00a7862.1160"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbon dioxide"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Carbon Dioxide Enzymatic Assay Kit and Control Set for quantitative determination of CO2 in serum and plasma.",
    "Indications for Use Summary": "Quantitative determination of carbon dioxide (CO2) in serum and plasma using Diazyme Carbon Dioxide Enzymatic Assay Kit with a calibrator; control set provides normal and abnormal reference levels.",
    "fda_folder": "Clinical Chemistry"
}